235 related articles for article (PubMed ID: 26668058)
1. Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains.
Gomes AV; Kazmierczak K; Cheah JX; Gilda JE; Yuan CC; Zhou Z; Szczesna-Cordary D
J Muscle Res Cell Motil; 2015 Dec; 36(6):447-61. PubMed ID: 26668058
[TBL] [Abstract][Full Text] [Related]
2. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin.
Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D
J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247
[TBL] [Abstract][Full Text] [Related]
4. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
[TBL] [Abstract][Full Text] [Related]
5. Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations.
Kazmierczak K; Yuan CC; Liang J; Huang W; Rojas AI; Szczesna-Cordary D
Front Physiol; 2014; 5():353. PubMed ID: 25295008
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.
Muthu P; Wang L; Yuan CC; Kazmierczak K; Huang W; Hernandez OM; Kawai M; Irving TC; Szczesna-Cordary D
FASEB J; 2011 Dec; 25(12):4394-405. PubMed ID: 21885653
[TBL] [Abstract][Full Text] [Related]
7. The role of the N-terminus of the myosin essential light chain in cardiac muscle contraction.
Kazmierczak K; Xu Y; Jones M; Guzman G; Hernandez OM; Kerrick WG; Szczesna-Cordary D
J Mol Biol; 2009 Apr; 387(3):706-25. PubMed ID: 19361417
[TBL] [Abstract][Full Text] [Related]
8. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
[TBL] [Abstract][Full Text] [Related]
9. Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice.
Yuan CC; Kazmierczak K; Liang J; Kanashiro-Takeuchi R; Irving TC; Gomes AV; Wang Y; Burghardt TP; Szczesna-Cordary D
Cardiovasc Res; 2017 Aug; 113(10):1124-1136. PubMed ID: 28371863
[TBL] [Abstract][Full Text] [Related]
10. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
[TBL] [Abstract][Full Text] [Related]
11. New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis.
Takahara S; Inoue SI; Miyagawa-Tomita S; Matsuura K; Nakashima Y; Niihori T; Matsubara Y; Saiki Y; Aoki Y
EBioMedicine; 2019 Apr; 42():43-53. PubMed ID: 30898653
[TBL] [Abstract][Full Text] [Related]
12. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
[TBL] [Abstract][Full Text] [Related]
13. Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies.
Tham YK; Huynh K; Mellett NA; Henstridge DC; Kiriazis H; Ooi JYY; Matsumoto A; Patterson NL; Sadoshima J; Meikle PJ; McMullen JR
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):219-234. PubMed ID: 29217479
[TBL] [Abstract][Full Text] [Related]
14. Deletion of 1-43 amino acids in cardiac myosin essential light chain blunts length dependency of Ca(2+) sensitivity and cross-bridge detachment kinetics.
Michael JJ; Gollapudi SK; Ford SJ; Kazmierczak K; Szczesna-Cordary D; Chandra M
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H253-9. PubMed ID: 23144314
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
16. Characterizations of myosin essential light chain's N-terminal truncation mutant Δ43 in transgenic mouse papillary muscles by using tension transients in response to sinusoidal length alterations.
Wang L; Muthu P; Szczesna-Cordary D; Kawai M
J Muscle Res Cell Motil; 2013 May; 34(2):93-105. PubMed ID: 23397074
[TBL] [Abstract][Full Text] [Related]
17. Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy.
Huang J; Shelton JM; Richardson JA; Kamm KE; Stull JT
J Biol Chem; 2008 Jul; 283(28):19748-56. PubMed ID: 18474588
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.
Huang W; Szczesna-Cordary D
J Muscle Res Cell Motil; 2015 Dec; 36(6):433-45. PubMed ID: 26385864
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of short-term preload-induced eccentric cardiac hypertrophy.
Mohamed BA; Asif AR; Schnelle M; Qasim M; Khadjeh S; Lbik D; Schott P; Hasenfuss G; Toischer K
J Transl Med; 2016 May; 14(1):149. PubMed ID: 27234427
[TBL] [Abstract][Full Text] [Related]
20. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
